Investigador Ramon y Cajal
Investigador Ramón y Cajal
![Foto de Investigador Ramon y Cajal](/img/noimage.png)
![Foto de Centro de Investigación en Red en Enfermedades Cardiovasculares](/img/noimage_org.png)
Centro de Investigación en Red en Enfermedades Cardiovasculares
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación en Red en Enfermedades Cardiovasculares (6)
2021
-
The miRNA199a/SIRT1/P300/Yy1/sST2 signaling axis regulates adverse cardiac remodeling following MI
Scientific Reports, Vol. 11, Núm. 1
2020
-
Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status (Scientific Reports, (2020), 10, 1, (13553), 10.1038/s41598-020-70454-8)
Scientific Reports
-
Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
Scientific Reports, Vol. 10, Núm. 1
2019
-
Identification of the first large intronic deletion responsible of type I antithrombin deficiency not detected by routine molecular diagnostic methods
British Journal of Haematology
-
The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure
Journal of the American College of Cardiology, Vol. 73, Núm. 9, pp. 1016-1025
-
p38γ is essential for cell cycle progression and liver tumorigenesis
Nature